Contrapaque 240mg Infusion bottle of 50 ml Infusion

Contrapaque 350mg Infusion is used as Diagnostic agent.

Iohexol 240mg

It is unsafe to consume alcohol with Contrapaque 240mg Infusion

Contrapaque 240mg Infusion is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.

• Keep yourself well hydrated before consumption of any contrast media to prevent any kidney damage.\n• Inform your doctor if you are diabetic or if you have cancer, pheochromocytoma (adrenal gland tumor), blood disorder (Sickle cell anemia) or thyroid disorder or if you have a history of fits (epilepsy), heart diseases, multiple sclerosis or alcoholism.\n• Seek immediate medical attention if you experience chest pain spreading to other parts of body, headache, and numbness after receiving iohexol. \n• Tell your doctor if you are pregnant, planning to become pregnant or are breastfeeding.\n• Patients allergic to Iohexol or any of its ingredients and any other iodinated contrast media should avoid taking it.\n• Patient with any local or systemic infection which may cause infection in blood (bacteremia) or receiving other medicine such as corticosteroids in case the contrast media has to be administered intrathecal (within the layers of spinal cord) should avoid taking Iohexol.

Iohexol : Nausea, Vomiting, Diarrhea

No interaction found/established

Iohexol belongs to a class of drugs known as radiographic contrast agents. It enhances imaging due to its high Iodine content attenuating the beam of X-rays during examination.

Q. How does Iohexol work?
Iohexol contains iodine and works by enhancing contrasts to body parts and fluids. Iohexol improves the images obtained during a CT scan for easily diagnose your condition

Q. Is Iohexol radioactive?
No, it is not radioactive

Q. Is Iohexol water soluble?
Yes. Iohexol is a water soluble iodinated contrast medium.

Contrapaque 240mg Infusion is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.